ERBB2 and ductal breast carcinoma in situ: Indeed, we identified a high concordance between the original patient sample and the DCIS-MIND models for the expression of hormone receptors, Ki67, and the surrogate molecular DCIS subtypes: luminal A, luminal B, HER2+, and basal DCIS (Figures 1G and 1H).